Skip to main content
PMC home page
Public Health Reports logoLink to Public Health Reports
. 1995 May-Jun;110(3):343–349.

Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response.

P Houck 1, M Patnode 1, R Atwood 1, K Powell 1
PMCID: PMC1382131  PMID: 7610228

Abstract

An outbreak of serogroup C meningococcal disease occurred in six counties in the State of Washington from January 1989 through mid-1991. This report describes epidemiologic data collected from hospitals and health departments, the results of multilocus enzyme electrophoresis of isolates, and the vaccination of high-risk populations in one county. A total of 45 confirmed or probable cases (10 per 100,000 population) occurred. Infants younger than age 1, Hispanics and American Indians, and low-income populations had high attack rates. Nine (20 percent) patients died. The predominant enzyme type, ET-22, had not been detected previously in Washington. More than 22,000 persons were vaccinated in one of the counties. Major challenges to health care personnel included deciding when and where to employ vaccination, obtaining sufficient vaccine, and responding to public anxiety.

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Artenstein M. S., Gold R., Zimmerly J. G., Wyle F. A., Schneider H., Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970 Feb 19;282(8):417–420. doi: 10.1056/NEJM197002192820803. [DOI] [PubMed] [Google Scholar]
  2. Bibb W. F., Schwartz B., Gellin B. G., Plikaytis B. D., Weaver R. E. Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol. 1989 Jun;8(3):233–239. doi: 10.1016/0168-1605(89)90018-4. [DOI] [PubMed] [Google Scholar]
  3. Corber S. Meningococcal disease and public health: welcome to the '90s. Can J Public Health. 1992 Mar-Apr;83(2):125–128. [PubMed] [Google Scholar]
  4. Corber S. Meningococcal disease and public health: welcome to the '90s. Can J Public Health. 1992 Mar-Apr;83(2):125–128. [PubMed] [Google Scholar]
  5. Counts G. W., Gregory D. F., Spearman J. G., Lee B. A., Filice G. A., Holmes K. K., Griffiss J. M. Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program. Rev Infect Dis. 1984 Sep-Oct;6(5):640–648. doi: 10.1093/clinids/6.5.640. [DOI] [PubMed] [Google Scholar]
  6. Farley J. D., Osei W. Invasive meningococcal disease, British Columbia. December 1991-March 1992. Can J Public Health. 1992 Mar-Apr;83(2):138–140. [PubMed] [Google Scholar]
  7. Gemmill I. An outbreak of meningococcal disease in Ottawa-Carleton. December 1991-February 1992. Can J Public Health. 1992 Mar-Apr;83(2):134–137. [PubMed] [Google Scholar]
  8. Gold R., Lepow M. L., Goldschneider I., Draper T. F., Gotshlich E. C. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J Infect Dis. 1979 Nov;140(5):690–697. doi: 10.1093/infdis/140.5.690. [DOI] [PubMed] [Google Scholar]
  9. Hume S. E. Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria. JAMA. 1992 Apr 1;267(13):1833-4, 1837-8. [PubMed] [Google Scholar]
  10. Jackson L. A., Schuchat A., Reeves M. W., Wenger J. D. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA. 1995 Feb 1;273(5):383–389. [PubMed] [Google Scholar]
  11. Pinner R. W., Gellin B. G., Bibb W. F., Baker C. N., Weaver R., Hunter S. B., Waterman S. H., Mocca L. F., Frasch C. E., Broome C. V. Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis. 1991 Aug;164(2):368–374. doi: 10.1093/infdis/164.2.368. [DOI] [PubMed] [Google Scholar]
  12. Pinner R. W., Gellin B. G., Bibb W. F., Baker C. N., Weaver R., Hunter S. B., Waterman S. H., Mocca L. F., Frasch C. E., Broome C. V. Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis. 1991 Aug;164(2):368–374. doi: 10.1093/infdis/164.2.368. [DOI] [PubMed] [Google Scholar]
  13. Selander R. K., Caugant D. A., Ochman H., Musser J. M., Gilmour M. N., Whittam T. S. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986 May;51(5):873–884. doi: 10.1128/aem.51.5.873-884.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sweet L. The Prince Edward Island meningococcal immunization program. January-February 1992. Can J Public Health. 1992 Mar-Apr;83(2):129–130. [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES